These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4466933)

  • 21. Deficiency of lymphocyte antigen recognition in Hodgkin's disease.
    Gaines JD; Gilmer MA; Remington JS
    Natl Cancer Inst Monogr; 1973 May; 36():117-21. PubMed ID: 4744572
    [No Abstract]   [Full Text] [Related]  

  • 22. [Lymphocyte blast transformation according to the clinical variant of rheumatoid arthritis].
    Popova L; Pekhlivanov D; Matev M; Apostolov P; Sheĭtanov I
    Vutr Boles; 1980; 19(2):39-43. PubMed ID: 6966867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current views on the mechanism of immunological disorders in Hodgkin's disease].
    Voĭtenkov BO; Letskiĭ VB; Gavrilenkova LP
    Eksp Onkol; 1984; 6(4):17-22. PubMed ID: 6389087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lymphocyte culture in the presence of phytohemagglutinins in Hodgkin's disease].
    Ferrari S; Foggi CM; Serafini NA
    Ann Ist Carlo Forlanini; 1968; 28(3):292-309. PubMed ID: 4903142
    [No Abstract]   [Full Text] [Related]  

  • 25. Spontaneous production of an inhibitor in vitro lymphocyte migration by lymphocytes from patients with Hodgkin's disease and mycosis fungoides.
    Skopińska-Rónzewska E; Zółtowska A; Dziewulska-Bokiniec A
    Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):57-62. PubMed ID: 6756337
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunosuppression: a paraneoplastic syndrome].
    Nagel GA
    Schweiz Med Wochenschr; 1971 Apr; 101(13):470-4. PubMed ID: 5283773
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 28. [Blast transformation of lymphocytes in subjects with malignant lymphogranuloma stimulated with phytohemagglutinin and with polyinosinic-polycytidylic acid (Poly-I: Poly-C). Comparison of the effects].
    Casirola G; Marini G; Ippoliti G
    Minerva Med; 1971 Dec; 62(97):4834-7. PubMed ID: 5131190
    [No Abstract]   [Full Text] [Related]  

  • 29. Lymphocyte response to pokeweed mitogen in Hodgkin's disease.
    Cohnen G; König E; Augener W; Brittinger G
    Biomedicine; 1973 Jun; 19(6):239-43. PubMed ID: 4752298
    [No Abstract]   [Full Text] [Related]  

  • 30. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
    Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recent findings in cellular immunodeficiency in lymphogranulomatosis].
    Müller G; Krüger W; Krug K; Hempel RD; Richter V; Rose H
    Radiobiol Radiother (Berl); 1983; 24(3):313-6. PubMed ID: 6635162
    [No Abstract]   [Full Text] [Related]  

  • 32. Lymphocyte sensitivity and cellular immunity in neoplasia.
    Faguet GB; Balcerzak SP; Lobuglio AF
    Biomedicine; 1973 Feb; 19(2):43-7. PubMed ID: 4731978
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma.
    ten Napel CH; van Egten-Bijker J; Halie MR; Langenhuysen MM; The TH
    J Clin Lab Immunol; 1980 Nov; 4(3):145-51. PubMed ID: 6259357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tests of immunological competence in lymphogranulomatosis with different antigens in lymphocyte culture.
    Heine KM; Stobbe H
    Helv Med Acta; 1967 Dec; 34(1):36-43. PubMed ID: 5592079
    [No Abstract]   [Full Text] [Related]  

  • 35. [Intracutaneous reaction to phytohemagglutinin in lymphogranulomatosis after a radical program of irradiation].
    Shishkin IP
    Med Radiol (Mosk); 1981 Apr; 26(4):8-10. PubMed ID: 7231070
    [No Abstract]   [Full Text] [Related]  

  • 36. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
    Passwell J; Levanon M; Davidsohn J; Ramot B
    Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune status of untreated patients with Hodgkin's disease and prognosis.
    Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of phytohemagglutinin on lymphocytes in Hodgkin's disease].
    Eggerth G; Kühböck J; Pokorny D
    Wien Z Inn Med; 1969; 50(7):314-9. PubMed ID: 5380683
    [No Abstract]   [Full Text] [Related]  

  • 39. [Anergy studies using the toxoplasmin test in lymphogranulomatosis].
    Wachtel D; Stammberger K; Metzel D; Drescher W
    Z Gesamte Inn Med; 1973 Oct; 28(20):623-8. PubMed ID: 4767197
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effect of radiotherapy on lymphocyte transformation in vitro in lymphogranulomatosis, reticulum cell sarcoma and bronchial carcinoma].
    Sobbe A; Wuttke H
    Strahlentherapie; 1973 Jun; 145(6):680-6. PubMed ID: 4615394
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.